UNSPSC 85543348: Occlusion of left axillary lymphatic with extraluminal device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left axillary lymphatic with extraluminal device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07L64CZ

UNSPSC 85543348 Occlusion of left axillary lymphatic with extraluminal device, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity. The code's clinical-procedure scope does not align with the state and local solicitations tagged under it in the recent-opportunities dataset. The most recent postings—independent medical evaluation services for disability pension determinations, surgical carve-out benefit programs for municipal employees, occupational health surveillance, specialty care for detained youth, pharmacy benefit management, and temporary health professional staffing—address medical administration, insurance benefits, occupational compliance, and workforce services rather than the specific axillary lymphatic procedure the code nominally describes. This mismatch suggests either a classification error in the source data or minimal actual procurement activity under this code at the state and local level.

The opportunities that do appear span multiple issuing bodies—a city pension office (Phoenix), two municipalities (Long Beach and Washington State Ferries), a county juvenile justice department (Harris County), a county benefits consortium (Collier County), and a regional health system (Santa Clara County)—and multiple service lines that have no meaningful connection to the code's intended commodity. Without state and local solicitations that genuinely require the procedure or device named in UNSPSC 85543348, this code presents no clear pursuit path for vendors offering that specific clinical service or product to state or local government.